Robert Charnas, Insider at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 2,293 shares at $33.24 ($76K) on 2017-01-20, disclosed to the SEC on 2017-01-24.
Scheduled sale ($76k) by Insider under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |